← Comparing 2 hypotheses side-by-side
Add hypothesis:
— Select a hypothesis to add —
Cell-Type-Specific TFEB Modulation Combined with Trehalose f (TFEB) — 0.00 Alpha-theta entrainment therapy to enhance default mode netw (SST) — 0.00 GLUT1-Mediated Carrier-Conjugate Delivery Strategy (LDLR) — 0.00 TBK1 Loss Triggers eIF2α-Mediated Translational Repression T (TBK1, EIF2S1) — 0.00 LDLR-Primed LRP1 Transcytosis with pH-Responsive Escape Stra (LDLR) — 0.00 LAMP2A Upregulation to Enhance Chaperone-Mediated Autophagy (LAMP2A) — 0.00 Closed-loop transcranial focused ultrasound with gamma entra (PVALB) — 0.00 TBK1 Loss Triggers Astrocyte-to-Neuron Senescence Propagatio (TBK1 → NF-κB / IRF3 / p62-autophagy / SASP effectors) — 0.00 Closed-loop transcranial focused ultrasound to restore hippo (SST) — 0.00 LAMP1 Overexpression to Enhance Lysosomal Capacity Independe (LAMP1) — 0.00 eIF2α Phosphorylation Imbalance Disrupts Mitochondrial Prote (EIF2S1,eIF2α,PERK,GCN2,ATF4,TOMM20,TIMM23,NDUFS1,NDUFS3,COX4I1,COX5A,mitochondrial protein import) — 0.00 LDLR-Mediated Neurosteroid Precursor Delivery Strategy (LDLR) — 0.00 Closed-loop transcranial focused ultrasound targeting EC-II (SST) — 0.97 GluN2B-Mediated Thalamocortical Control of Glymphatic Tau Cl (GRIN2B) — 0.96 Closed-loop optogenetic targeting PV interneurons to restore (PVALB) — 0.96 Closed-loop transcranial focused ultrasound targeting EC-II (SST) — 0.96 Cortico-Striatal Synchrony Restoration via NMDA Modulation (GRIN2B) — 0.95 Gamma entrainment therapy to restore hippocampal-cortical sy (SST) — 0.95 Plasma NfL Elevation Secondary to BBB-Associated Transport D (NEFL) — 0.94 Microglial-Mediated Tau Clearance Dysfunction via TREM2 Rece (MAPT) — 0.94 Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming (NLRP3, CASP1, IL1B, PYCARD) — 0.92 Closed-loop transcranial focused ultrasound to restore hippo (CCK) — 0.91 eIF2α Phosphorylation Imbalance Creates Integrated Stress Re (EIF2S1,eIF2α,PERK,GCN2,ATF4,ATF5,CHOP,DDIT3,integrated stress response,protein synthesis) — 0.90 APOE-Dependent Autophagy Restoration (MTOR) — 0.89 Hypothesis 4: Metabolic Coupling via Lactate-Shuttling Colla (SLC16A1, SLC16A7, LDHA, PDHA1) — 0.89 p38α Inhibitor and PRMT1 Activator Combination to Restore Ph (MAPK14/PRMT1) — 0.89 SIRT1-Mediated Reversal of TREM2-Dependent Microglial Senesc (SIRT1) — 0.89 TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegener (TREM2) — 0.89 ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro (ACSL4) — 0.89 Multi-Target Hypothesis: Aβ-Induced Cholinergic Damage is Pa (APP/PSEN1 (Aβ production), CHAT (cholinergic synthesis)) — 0.89
Add
|
× Gut-BBB Axis: Tributyrin/ × Pericyte-First Sequential
CLDN5 · - · -
Composite 0.712
Price $0.53
Evidence For 0
Evidence Against 0
Gut dysbiosis-driven butyrate deficit causes HDAC-mediated silencing of CLDN5 in brain endothelial cells; tributyrin prodrug restores CLDN5 expression via H3K27ac enrichment at the CLDN5 promoter, re-sealing the BBB in a virtuous cycle linking gut microbiome to neurovascular integrity.
PDGFRB · - · -
Composite 0.662
Price $0.53
Evidence For 0
Evidence Against 0
CSF soluble PDGFR-β shedding from pericytes as the earliest detectable molecular event in AD, preceding amyloid/tau pathology and exploitable as a 'zero-stage' biomarker via ADAM10/17-mediated ectodomain shedding. Biomarker utility is strong; therapeutic translation requires novel PDGFR-β agonism or ADAM10/17-selective CNS inhibition.
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
Vascular Barrier Glymphatic
Convergent signals
No same-target convergence detected in this selection.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary 6/11
dimensions won
Gut-BBB Axis: Tributyrin/Butyrate HDAC I
5/11
dimensions won
Pericyte-First Sequential Biomarker Casc
Radar Chart — 10 Dimensions
Score Breakdown
Dimension Gut-BBB Axis: Tributyrin/Butyr Pericyte-First Sequential Biom Mechanistic 0.650 0.820 Evidence 0.740 0.180 Novelty 0.720 0.760 Feasibility 0.820 0.680 Impact 0.000 0.000 Druggability 0.780 0.420 Safety 0.720 0.480 Competition 0.600 0.650 Data 0.700 0.800 Reproducible 0.780 0.740 KG Connect 0.500 0.500
Evidence Gut-BBB Axis: Tributyrin/Butyrate HDAC Inhibition Epigenetic No evidence citations yet
Pericyte-First Sequential Biomarker Cascade — Soluble PDGFR- No evidence citations yet
Price History Overlay
Knowledge Graph Comparison
Gut-BBB Axis: Tributyrin/Butyrate HDAC I
1 edges
Top Node Types debate_session_causal 1
Top Relations causal_extracted 1
Pericyte-First Sequential Biomarker Casc
1 edges
Top Node Types debate_session_causal 1
Top Relations causal_extracted 1